ID   GAK_HUMAN               Reviewed;        1311 AA.
AC   O14976; Q5U4P5; Q9BVY6;
DT   29-AUG-2001, integrated into UniProtKB/Swiss-Prot.
DT   29-AUG-2001, sequence version 2.
DT   12-APR-2017, entry version 168.
DE   RecName: Full=Cyclin-G-associated kinase;
DE            EC=2.7.11.1;
GN   Name=GAK;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND CHARACTERIZATION.
RC   TISSUE=Fibroblast;
RX   PubMed=9299234; DOI=10.1006/geno.1997.4873;
RA   Kimura S.H., Tsuruga H., Yabuta N., Endo Y., Nojima H.;
RT   "Structure, expression, and chromosomal localization of human GAK.";
RL   Genomics 44:179-187(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 981-1311 (ISOFORM 1).
RC   TISSUE=Ovary, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=10625686; DOI=10.1074/jbc.275.2.1365;
RA   Greener T., Zhao X., Nojima H., Eisenberg E., Greene L.E.;
RT   "Role of cyclin G-associated kinase in uncoating clathrin-coated
RT   vesicles from non-neuronal cells.";
RL   J. Biol. Chem. 275:1365-1370(2000).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-16; SER-456; SER-770;
RP   SER-826; SER-829; SER-834 AND SER-1096, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-826; SER-829 AND
RP   SER-834, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [6]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [7]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, PHOSPHORYLATION [LARGE
RP   SCALE ANALYSIS] AT SER-16; SER-826; SER-829; SER-834; SER-939;
RP   SER-1176 AND SER-1185, CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE
RP   ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-826 AND SER-829, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-829, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-776; THR-794; SER-826
RP   AND SER-829, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-783, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 12-347.
RG   Midwest center for structural genomics (MCSG);
RT   "Crystal structure of the human cyclin G associated kinase (GAK).";
RL   Submitted (JUL-2011) to the PDB data bank.
RN   [14]
RP   VARIANTS [LARGE SCALE ANALYSIS] LEU-144; MET-580; TYR-787; ARG-877;
RP   ASP-962; MET-1051; HIS-1120; LEU-1137; ASN-1168; ARG-1265 AND
RP   ASN-1297.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Associates with cyclin G and CDK5. Seems to act as an
CC       auxilin homolog that is involved in the uncoating of clathrin-
CC       coated vesicles by Hsc70 in non-neuronal cells. Expression
CC       oscillates slightly during the cell cycle, peaking at G1.
CC       {ECO:0000269|PubMed:10625686}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- INTERACTION:
CC       Q9NQ11:ATP13A2; NbExp=2; IntAct=EBI-714707, EBI-6308763;
CC       P11142:HSPA8; NbExp=5; IntAct=EBI-714707, EBI-351896;
CC       Q5S007:LRRK2; NbExp=10; IntAct=EBI-714707, EBI-5323863;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, perinuclear region
CC       {ECO:0000269|PubMed:10625686}. Golgi apparatus, trans-Golgi
CC       network {ECO:0000269|PubMed:10625686}. Cell junction, focal
CC       adhesion {ECO:0000305|PubMed:10625686}. Note=Localizes to the
CC       perinuclear area and to the trans-Golgi network. Also seen on the
CC       plasma membrane, probably at focal adhesions.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=O14976-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O14976-2; Sequence=VSP_054479;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Ubiquitous. Highest in testis.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Ser/Thr
CC       protein kinase family. {ECO:0000255|PROSITE-ProRule:PRU00159}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D88435; BAA22623.1; -; mRNA.
DR   EMBL; BC000816; AAH00816.1; -; mRNA.
DR   EMBL; BC008668; AAH08668.1; -; mRNA.
DR   EMBL; BC085005; AAH85005.1; -; mRNA.
DR   CCDS; CCDS3340.1; -. [O14976-1]
DR   CCDS; CCDS82902.1; -. [O14976-2]
DR   RefSeq; NP_001305063.1; NM_001318134.1. [O14976-2]
DR   RefSeq; NP_005246.2; NM_005255.3. [O14976-1]
DR   UniGene; Hs.369607; -.
DR   PDB; 4C57; X-ray; 2.55 A; A/B=14-351.
DR   PDB; 4C58; X-ray; 2.16 A; A=27-351.
DR   PDB; 4C59; X-ray; 2.80 A; A=14-351.
DR   PDB; 4O38; X-ray; 2.10 A; A/B=12-347.
DR   PDB; 4Y8D; X-ray; 2.10 A; A/B=14-351.
DR   PDBsum; 4C57; -.
DR   PDBsum; 4C58; -.
DR   PDBsum; 4C59; -.
DR   PDBsum; 4O38; -.
DR   PDBsum; 4Y8D; -.
DR   ProteinModelPortal; O14976; -.
DR   SMR; O14976; -.
DR   BioGrid; 108853; 92.
DR   IntAct; O14976; 80.
DR   MINT; MINT-5000432; -.
DR   STRING; 9606.ENSP00000314499; -.
DR   BindingDB; O14976; -.
DR   ChEMBL; CHEMBL4355; -.
DR   GuidetoPHARMACOLOGY; 2027; -.
DR   iPTMnet; O14976; -.
DR   PhosphoSitePlus; O14976; -.
DR   BioMuta; GAK; -.
DR   EPD; O14976; -.
DR   MaxQB; O14976; -.
DR   PaxDb; O14976; -.
DR   PeptideAtlas; O14976; -.
DR   PRIDE; O14976; -.
DR   DNASU; 2580; -.
DR   Ensembl; ENST00000314167; ENSP00000314499; ENSG00000178950. [O14976-1]
DR   Ensembl; ENST00000511163; ENSP00000421361; ENSG00000178950. [O14976-2]
DR   GeneID; 2580; -.
DR   KEGG; hsa:2580; -.
DR   UCSC; uc003gbm.6; human. [O14976-1]
DR   CTD; 2580; -.
DR   DisGeNET; 2580; -.
DR   GeneCards; GAK; -.
DR   H-InvDB; HIX0004007; -.
DR   HGNC; HGNC:4113; GAK.
DR   HPA; HPA027405; -.
DR   HPA; HPA027459; -.
DR   HPA; HPA027463; -.
DR   MIM; 602052; gene.
DR   neXtProt; NX_O14976; -.
DR   OpenTargets; ENSG00000178950; -.
DR   PharmGKB; PA28528; -.
DR   eggNOG; KOG0431; Eukaryota.
DR   eggNOG; KOG1989; Eukaryota.
DR   eggNOG; KOG2283; Eukaryota.
DR   eggNOG; ENOG410Y515; LUCA.
DR   GeneTree; ENSGT00870000136426; -.
DR   HOGENOM; HOG000034235; -.
DR   HOVERGEN; HBG004322; -.
DR   InParanoid; O14976; -.
DR   KO; K08855; -.
DR   OMA; KKNNIRA; -.
DR   OrthoDB; EOG091G06HJ; -.
DR   PhylomeDB; O14976; -.
DR   TreeFam; TF105165; -.
DR   Reactome; R-HSA-432722; Golgi Associated Vesicle Biogenesis.
DR   Reactome; R-HSA-8856828; Clathrin-mediated endocytosis.
DR   SignaLink; O14976; -.
DR   ChiTaRS; GAK; human.
DR   GeneWiki; GAK_(protein); -.
DR   GenomeRNAi; 2580; -.
DR   PRO; PR:O14976; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000178950; -.
DR   CleanEx; HS_GAK; -.
DR   ExpressionAtlas; O14976; baseline and differential.
DR   Genevisible; O14976; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005925; C:focal adhesion; IEA:UniProtKB-SubCell.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0045202; C:synapse; IEA:GOC.
DR   GO; GO:0031982; C:vesicle; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0051087; F:chaperone binding; TAS:BHF-UCL.
DR   GO; GO:0030332; F:cyclin binding; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; TAS:ProtInc.
DR   GO; GO:0007049; P:cell cycle; IEA:UniProtKB-KW.
DR   GO; GO:0051085; P:chaperone mediated protein folding requiring cofactor; TAS:BHF-UCL.
DR   GO; GO:0072318; P:clathrin coat disassembly; IMP:ParkinsonsUK-UCL.
DR   GO; GO:1905224; P:clathrin-coated pit assembly; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0072583; P:clathrin-dependent endocytosis; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0007029; P:endoplasmic reticulum organization; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0072600; P:establishment of protein localization to Golgi; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0090002; P:establishment of protein localization to plasma membrane; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0007030; P:Golgi organization; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0090160; P:Golgi to lysosome transport; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0061024; P:membrane organization; TAS:Reactome.
DR   GO; GO:0010977; P:negative regulation of neuron projection development; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0006898; P:receptor-mediated endocytosis; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0016191; P:synaptic vesicle uncoating; ISS:BHF-UCL.
DR   CDD; cd06257; DnaJ; 1.
DR   Gene3D; 1.10.287.110; -; 1.
DR   Gene3D; 3.90.190.10; -; 1.
DR   InterPro; IPR000008; C2_dom.
DR   InterPro; IPR001623; DnaJ_domain.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR029021; Prot-tyrosine_phosphatase-like.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   InterPro; IPR014020; Tensin_C2-dom.
DR   InterPro; IPR029023; Tensin_phosphatase.
DR   Pfam; PF00069; Pkinase; 1.
DR   Pfam; PF10409; PTEN_C2; 1.
DR   SMART; SM00271; DnaJ; 1.
DR   SMART; SM01326; PTEN_C2; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF46565; SSF46565; 1.
DR   SUPFAM; SSF49562; SSF49562; 1.
DR   SUPFAM; SSF52799; SSF52799; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS51182; C2_TENSIN; 1.
DR   PROSITE; PS50076; DNAJ_2; 1.
DR   PROSITE; PS51181; PPASE_TENSIN; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; ATP-binding;
KW   Cell cycle; Cell junction; Complete proteome; Cytoplasm;
KW   Golgi apparatus; Kinase; Methylation; Nucleotide-binding;
KW   Phosphoprotein; Polymorphism; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:19413330}.
FT   CHAIN         2   1311       Cyclin-G-associated kinase.
FT                                /FTId=PRO_0000085958.
FT   DOMAIN       40    314       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   DOMAIN      399    566       Phosphatase tensin-type.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00590}.
FT   DOMAIN      572    710       C2 tensin-type. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00589}.
FT   DOMAIN     1247   1311       J. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00286}.
FT   COMPBIAS    347    350       Poly-Pro.
FT   ACT_SITE    173    173       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   MOD_RES       2      2       N-acetylserine.
FT                                {ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:19413330}.
FT   MOD_RES       2      2       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P97874}.
FT   MOD_RES      16     16       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:19369195}.
FT   MOD_RES     456    456       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976}.
FT   MOD_RES     770    770       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976}.
FT   MOD_RES     776    776       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     783    783       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     794    794       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     811    811       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P97874}.
FT   MOD_RES     826    826       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     829    829       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     834    834       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:19369195}.
FT   MOD_RES     939    939       Phosphoserine.
FT                                {ECO:0000244|PubMed:19369195}.
FT   MOD_RES    1096   1096       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976}.
FT   MOD_RES    1123   1123       Omega-N-methylarginine.
FT                                {ECO:0000250|UniProtKB:Q99KY4}.
FT   MOD_RES    1176   1176       Phosphoserine.
FT                                {ECO:0000244|PubMed:19369195}.
FT   MOD_RES    1185   1185       Phosphoserine.
FT                                {ECO:0000244|PubMed:19369195}.
FT   VAR_SEQ      49    127       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_054479.
FT   VARIANT     144    144       S -> L (in dbSNP:rs768962219).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040505.
FT   VARIANT     580    580       V -> M (in dbSNP:rs34255232).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040506.
FT   VARIANT     787    787       D -> Y (in dbSNP:rs34585705).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040507.
FT   VARIANT     877    877       Q -> R (in dbSNP:rs149842313).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040508.
FT   VARIANT     962    962       G -> D (in a lung neuroendocrine
FT                                carcinoma sample; somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040509.
FT   VARIANT    1051   1051       T -> M (in dbSNP:rs35227944).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040510.
FT   VARIANT    1120   1120       Q -> H (in dbSNP:rs55801437).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040511.
FT   VARIANT    1137   1137       P -> L (in dbSNP:rs56169884).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040512.
FT   VARIANT    1168   1168       S -> N (in dbSNP:rs56326341).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040513.
FT   VARIANT    1265   1265       K -> R (in dbSNP:rs2306242).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040514.
FT   VARIANT    1297   1297       D -> N (in dbSNP:rs1134921).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040515.
FT   CONFLICT    607    607       R -> C (in Ref. 2; AAH85005).
FT                                {ECO:0000305}.
FT   CONFLICT   1113   1113       P -> A (in Ref. 1; BAA22623).
FT                                {ECO:0000305}.
FT   TURN         27     30       {ECO:0000244|PDB:4O38}.
FT   STRAND       32     35       {ECO:0000244|PDB:4O38}.
FT   STRAND       38     47       {ECO:0000244|PDB:4O38}.
FT   STRAND       50     59       {ECO:0000244|PDB:4O38}.
FT   TURN         60     62       {ECO:0000244|PDB:4O38}.
FT   STRAND       65     75       {ECO:0000244|PDB:4O38}.
FT   HELIX        76     92       {ECO:0000244|PDB:4O38}.
FT   STRAND      101    107       {ECO:0000244|PDB:4O38}.
FT   TURN        109    111       {ECO:0000244|PDB:4O38}.
FT   STRAND      115    124       {ECO:0000244|PDB:4O38}.
FT   STRAND      127    129       {ECO:0000244|PDB:4O38}.
FT   HELIX       130    138       {ECO:0000244|PDB:4O38}.
FT   HELIX       145    163       {ECO:0000244|PDB:4O38}.
FT   STRAND      165    167       {ECO:0000244|PDB:4O38}.
FT   HELIX       176    178       {ECO:0000244|PDB:4O38}.
FT   STRAND      179    181       {ECO:0000244|PDB:4Y8D}.
FT   STRAND      187    189       {ECO:0000244|PDB:4O38}.
FT   HELIX       208    221       {ECO:0000244|PDB:4C57}.
FT   HELIX       224    226       {ECO:0000244|PDB:4C57}.
FT   HELIX       229    232       {ECO:0000244|PDB:4C57}.
FT   HELIX       242    258       {ECO:0000244|PDB:4O38}.
FT   TURN        262    265       {ECO:0000244|PDB:4C57}.
FT   HELIX       268    272       {ECO:0000244|PDB:4C57}.
FT   HELIX       286    288       {ECO:0000244|PDB:4O38}.
FT   HELIX       289    295       {ECO:0000244|PDB:4O38}.
FT   HELIX       300    302       {ECO:0000244|PDB:4O38}.
FT   HELIX       306    319       {ECO:0000244|PDB:4O38}.
FT   HELIX       329    332       {ECO:0000244|PDB:4O38}.
SQ   SEQUENCE   1311 AA;  143191 MW;  0ACE45DF57A5F981 CRC64;
     MSLLQSALDF LAGPGSLGGA SGRDQSDFVG QTVELGELRL RVRRVLAEGG FAFVYEAQDV
     GSGREYALKR LLSNEEEKNR AIIQEVCFMK KLSGHPNIVQ FCSAASIGKE ESDTGQAEFL
     LLTELCKGQL VEFLKKMESR GPLSCDTVLK IFYQTCRAVQ HMHRQKPPII HRDLKVENLL
     LSNQGTIKLC DFGSATTISH YPDYSWSAQR RALVEEEITR NTTPMYRTPE IIDLYSNFPI
     GEKQDIWALG CILYLLCFRQ HPFEDGAKLR IVNGKYSIPP HDTQYTVFHS LIRAMLQVNP
     EERLSIAEVV HQLQEIAAAR NVNPKSPITE LLEQNGGYGS ATLSRGPPPP VGPAGSGYSG
     GLALAEYDQP YGGFLDILRG GTERLFTNLK DTSSKVIQSV ANYAKGDLDI SYITSRIAVM
     SFPAEGVESA LKNNIEDVRL FLDSKHPGHY AVYNLSPRTY RPSRFHNRVS ECGWAARRAP
     HLHTLYNICR NMHAWLRQDH KNVCVVHCMD GRAASAVAVC SFLCFCRLFS TAEAAVYMFS
     MKRCPPGIWP SHKRYIEYMC DMVAEEPITP HSKPILVRAV VMTPVPLFSK QRSGCRPFCE
     VYVGDERVAS TSQEYDKMRD FKIEDGKAVI PLGVTVQGDV LIVIYHARST LGGRLQAKMA
     SMKMFQIQFH TGFVPRNATT VKFAKYDLDA CDIQEKYPDL FQVNLEVEVE PRDRPSREAP
     PWENSSMRGL NPKILFSSRE EQQDILSKFG KPELPRQPGS TAQYDAGAGS PEAEPTDSDS
     PPSSSADASR FLHTLDWQEE KEAETGAENA SSKESESALM EDRDESEVSD EGGSPISSEG
     QEPRADPEPP GLAAGLVQQD LVFEVETPAV LPEPVPQEDG VDLLGLHSEV GAGPAVPPQA
     CKAPSSNTDL LSCLLGPPEA ASQGPPEDLL SEDPLLLASP APPLSVQSTP RGGPPAAADP
     FGPLLPSSGN NSQPCSNPDL FGEFLNSDSV TVPPSFPSAH SAPPPSCSAD FLHLGDLPGE
     PSKMTASSSN PDLLGGWAAW TETAASAVAP TPATEGPLFS PGGQPAPCGS QASWTKSQNP
     DPFADLGDLS SGLQGSPAGF PPGGFIPKTA TTPKGSSSWQ TSRPPAQGAS WPPQAKPPPK
     ACTQPRPNYA SNFSVIGARE ERGVRAPSFA QKPKVSENDF EDLLSNQGFS SRSDKKGPKT
     IAEMRKQDLA KDTDPLKLKL LDWIEGKERN IRALLSTLHT VLWDGESRWT PVGMADLVAP
     EQVKKHYRRA VLAVHPDKAA GQPYEQHAKM IFMELNDAWS EFENQGSRPL F
//
